SCHEMBL17098940

SCHEMBL17098940

O=C(c1cnn([C@H]2CC[C@H](C(=O)O)CC2)c1C(F)(F)F)N(CCc1c(Cl)cccc1Cl)Cc1ccc(Cl)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.36
MBTPS1 Q14703 1/20 0.36
LPAR1 Q92633 1/20 0.34
LPAR5 Q9H1C0 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
AGTR2 P50052 2/20 0.33
ALDH1A1 P00352 3/20 0.33
OPRM1 P35372 2/20 0.33
OPRD1 P41143 2/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KLKB1 P03952 1/20 0.33
GAA P10253 2/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
AGER Q15109 1/20 0.32
NR3C1 P04150 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17098942 1.00 C5AR1 (0.36) C5AR1MBTPS1LPAR1LPAR5MEN1
SCHEMBL17098036 0.94 NR3C1 (0.38) MBTPS1LPAR1LPAR5AGTR2OPRM1
SCHEMBL17098039 0.94 NR3C1 (0.38) MBTPS1LPAR1LPAR5AGTR2OPRM1
SCHEMBL17097950 0.92 C5AR1 (0.45) C5AR1LPAR1LPAR5MEN1KMT2A
SCHEMBL17097947 0.92 C5AR1 (0.45) C5AR1LPAR1LPAR5MEN1KMT2A
SCHEMBL17097880 0.91 C5AR1 (0.38) C5AR1MBTPS1MEN1KMT2AAGTR2
SCHEMBL17097877 0.91 C5AR1 (0.38) C5AR1MBTPS1MEN1KMT2AAGTR2
SCHEMBL17098103 0.89 GAA (0.37) MBTPS1LPAR1LPAR5ALDH1A1OPRM1
SCHEMBL17098286 0.89 EPHX2 (0.37) C5AR1MEN1KMT2AAGTR2ALDH1A1
SCHEMBL17098289 0.89 EPHX2 (0.37) C5AR1MEN1KMT2AAGTR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA C5AR1 2866/4885MBTPS1 1547/4885LPAR1 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.